Efficacy of Adding Oral Simvastatin to Topical Therapy for Treatment of Psoriasis: The Vietnamese Experience

BACKGROUND: Psoriasis, the prevalence of which ranges from 2% to 3% of the general population, has been recently recognised as not only a chronic inflammatory skin disorder but also an immunometabolic systemic disease. Dyslipidemia is one of the most important comorbidities of psoriasis. Statins, fr...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Open Access Maced J Med Sci
Main Authors: Trong, Hao Nguyen, Tat, Thang Nguyen, Anh, Tu Tran Nguyen, Uyen, Nhi Pham, Van, Thuong Nguyen, Hau, Khang Tran, Gandolfi, Marco, Satolli, Francesca, Feliciani, Claudio, Tirant, Michael, Vojvodic, Aleksandra, Lotti, Torello
Formato: Artigo
Idioma:Inglês
Publicado: Republic of Macedonia 2019
Assuntos:
Clinical Science
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6364708/
https://ncbi.nlm.nih.gov/pubmed/30745969
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3889/oamjms.2019.060
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares